RBC Capital Maintains Outperform on Celestica, Raises Price Target to $38
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Maxim Matushansky has maintained an Outperform rating on Celestica (NYSE:CLS) and increased the price target from $33 to $38.
January 31, 2024 | 3:24 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
RBC Capital analyst Maxim Matushansky reaffirms an Outperform rating on Celestica and raises the price target from $33 to $38, indicating a positive outlook on the stock.
The increase in price target by a reputable analyst typically signals a positive forecast for the company's stock performance and can lead to increased investor confidence, potentially driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100